A detailed history of New York State Common Retirement Fund transactions in Nkarta, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 8,455 shares of NKTX stock, worth $19,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,455
Previous 8,455 -0.0%
Holding current value
$19,869
Previous $50,000 24.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$5.27 - $10.82 $94 - $194
18 Added 0.21%
8,455 $50,000
Q1 2024

May 07, 2024

BUY
$5.59 - $15.71 $11,006 - $30,932
1,969 Added 30.44%
8,437 $91,000
Q4 2023

Feb 01, 2024

SELL
$1.31 - $6.6 $61 - $310
-47 Reduced 0.72%
6,468 $43,000
Q3 2023

Nov 07, 2023

BUY
$1.39 - $2.29 $127 - $210
92 Added 1.43%
6,515 $9,000
Q2 2023

Aug 07, 2023

SELL
$2.19 - $5.17 $131 - $310
-60 Reduced 0.93%
6,423 $14,000
Q1 2023

May 02, 2023

SELL
$3.37 - $6.3 $54,594 - $102,060
-16,200 Reduced 71.42%
6,483 $23,000
Q4 2022

Jan 30, 2023

SELL
$5.14 - $14.35 $118 - $330
-23 Reduced 0.1%
22,683 $136,000
Q3 2022

Nov 08, 2022

BUY
$12.27 - $18.39 $2,417 - $3,622
197 Added 0.88%
22,706 $299,000
Q2 2022

Aug 04, 2022

BUY
$7.77 - $19.44 $104,793 - $262,187
13,487 Added 149.49%
22,509 $277,000
Q1 2022

May 05, 2022

BUY
$8.66 - $14.99 $95 - $164
11 Added 0.12%
9,022 $103,000
Q4 2021

Feb 02, 2022

SELL
$12.79 - $26.88 $460 - $967
-36 Reduced 0.4%
9,011 $138,000
Q3 2021

Nov 02, 2021

SELL
$26.67 - $38.76 $85,984 - $124,962
-3,224 Reduced 26.27%
9,047 $252,000
Q2 2021

Aug 02, 2021

SELL
$23.94 - $36.68 $60,544 - $92,763
-2,529 Reduced 17.09%
12,271 $389,000
Q4 2020

Feb 08, 2021

BUY
$27.03 - $75.62 $200,022 - $559,588
7,400 Added 100.0%
14,800 $910,000
Q3 2020

Nov 05, 2020

BUY
$23.52 - $47.9 $174,048 - $354,460
7,400 New
7,400 $222,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.